Fluorene

Fluorene

SCHEMBL17889181

c1ccc2c(c1)Cc1ccccc1-2.c1ccc2c(c1)sc1ccccc12

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.61
MAOA P21397 1/20 0.46
ALDH1A1 P00352 4/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 1/20 0.44
MAP3K9 P80192 2/20 0.41
MAP3K11 Q16584 2/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA4 P22748 1/20 0.40
CA6 P23280 1/20 0.40
DRD2 P14416 1/20 0.39
DRD1 P21728 1/20 0.39
DRD4 P21917 1/20 0.39
DRD5 P21918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluorene SCHEMBL22714164 0.88 KDM4E (0.50) GPR3MAOAALDH1A1MAPTHPGD
SCHEMBL17953627 0.88 GPR3 (0.47) GPR3MAOAALDH1A1MAPTHPGD
SCHEMBL17953634 0.88 GPR3 (0.47) GPR3MAOAALDH1A1MAPTHPGD
SCHEMBL17431182 0.83 GPR3 (0.42) GPR3MAOAALDH1A1MAPTHPGD
SCHEMBL17431157 0.83 GPR3 (0.42) GPR3MAOAALDH1A1MAPTHPGD
SCHEMBL17431145 0.82 GPR3 (0.41) GPR3MAOAALDH1A1MAPTHPGD
SCHEMBL23340618 0.81 GPR3 (0.40) GPR3MAOAALDH1A1MAPTHPGD
Triphenylene SCHEMBL21360057 0.81 MAOA (0.59) MAOAALDH1A1MAPTHPGDRAB9A
SCHEMBL17953636 0.79 MAP3K9 (0.46) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL17954609 0.79 MAP3K9 (0.46) GPR3MAOAALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106458954-B Condensed fluorene derivative containing heterocycle SFC株式会社 2022-06-28 CN disclosed
CN-106458953-B Heterocyclic compound containing aromatic amino group and organic light-emitting element containing the same SFC株式会社 2021-12-10 CN disclosed
EP-3043398-B1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORP (US) 2018-04-04 EP disclosed
CN-106458953-A Heterocyclic compound containing aromatic amine group, and organic light-emitting device comprising same SFC株式会社 2017-02-22 CN disclosed
CN-106458954-A Condensed fluorene derivative containing heterocycle SFC株式会社 2017-02-22 CN disclosed
US-9406892-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2016-08-02 US disclosed
EP-3043398-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2016-07-13 EP disclosed
US-20160197285-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160197285-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES AOX1, OCIAD2, OCIAD1 GPR3 2718/4885MAOA 508/4885ALDH1A1 976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.